3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow CBD: new trials by email Literature Review of CBD trials Research Report on CBD
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus Tacrolimus single dose, Epidiolex single dose, Epidiolex steady-state and tacrolimus single dose - CBD, Transplant Complication | Phase 1 | Completed | Indiana University | 57 | 2022-10-31 | 2026-09-30 |
| A Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults CBD and THC with GT4 technology - Biological Availability, Skin Absorption | Phase 1 | Completed | Gefion Canada Inc. | 18 | 2021-11-27 | 2022-06-01 |
| A Study of Cybis™ 10:25 THC:CBD Oil in Adults With Chronic Back/Neck Pain Cybis™ 10:25 THC:CBD oil - Chronic Pain, Neck Pain | Phase 1 / Phase 2 | Completed | Cymra Life Sciences | 28 | 2021-09-20 | 2022-07-07 |
Back Pain (1) · Chronic Pain (1) · Neck Pain (1) · Pain (1) · Renal Insufficiency, Chronic (1)
Pathological Conditions, Signs and Symptoms (2) · Chronic Disease (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Neurologic Manifestations (1) · Pathologic Processes (1) · Renal Insufficiency (1) · Signs and Symptoms (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Cannabidiol (1) · Dronabinol (1) · Tacrolimus (1)
Cymra Life Sciences (1) · Gefion Canada Inc. (1) · Indiana University (1)
Australia (1) · Canada (1) · United States (1)
David Crowley, MD (1) · Michael Eadon, MD (1) · Richard Chye (1) · Zeruesenay Desta, PhD (1)
PMID 36308640, PMID 39601108, PMID 41252210
R01AT011463 (1)